Sign in

CIK 0001787400

  • Non-accelerated filer
  • Smaller reporting company

Nkarta, Inc.

Sign in to watch
Ticker
NKTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
474515206
Phone
+1 925-407-1049
Business address
1150 VETERANS BOULEVARD, SOUTH SAN FRANCISCO, CA, 94080
  1. 4 Open-market sale Chief Medical Officer sold 439 shares at $4.85 ($2,129)
  2. 4 Open-market sale Mahmood Nadir sold 526 shares at $4.85 ($2,551)
  3. 4 Open-market sale Chief Executive Officer sold 1,704 shares at $4.85 ($8,264)
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Open-market sale Chief Scientific Officer sold 1,115 shares at $5.49 ($6,121)
  13. 4 Open-market sale Chief Medical Officer sold 175 shares at $5.49 ($961)
  14. 4 Open-market sale Mahmood Nadir sold 1,122 shares at $5.49 ($6,160)
  15. 4 Open-market sale Chief Executive Officer sold 3,691 shares at $5.49 ($20,264)
  16. 4 Open-market sale Chief Legal Officer sold 1,103 shares at $5.49 ($6,055)
  17. 4 Open-market sale Chief Technical Officer sold 491 shares at $5.49 ($2,696)
  18. 3 Insider Initial Statement of Ownership
  19. 4 Open-market sale Chief Technical Officer sold 842 shares at $14.02 ($11,805)
  20. 4 Open-market sale Chief Executive Officer sold 23,874 shares at an average $13.03 ($311,089)

Page 5 of 11 · 218 filings